Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Gross Profit: 2012-2025

Historic Gross Profit for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to $11.2 million.

  • Agios Pharmaceuticals' Gross Profit rose 36.91% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.1 million, marking a year-over-year increase of 32.96%. This contributed to the annual value of $32.3 million for FY2024, which is 35.05% up from last year.
  • As of Q3 2025, Agios Pharmaceuticals' Gross Profit stood at $11.2 million, which was up 4.17% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Gross Profit registered a high of $11.2 million during Q3 2025, and its lowest value of $493,000 during Q1 2022.
  • For the 3-year period, Agios Pharmaceuticals' Gross Profit averaged around $7.8 million, with its median value being $7.6 million (2024).
  • Data for Agios Pharmaceuticals' Gross Profit shows a peak YoY soared of 925.35% (in 2023) over the last 5 years.
  • Agios Pharmaceuticals' Gross Profit (Quarterly) stood at $3.9 million in 2022, then skyrocketed by 67.23% to $6.5 million in 2023, then spiked by 45.31% to $9.5 million in 2024, then surged by 36.91% to $11.2 million in 2025.
  • Its Gross Profit was $11.2 million in Q3 2025, compared to $10.8 million in Q2 2025 and $7.6 million in Q1 2025.